Floatz logo

GLYCERIN,ANHYDROUS

Obesity, Visceral

University of Texas Southwestern Medical CenterSmall moleculePhase 4 / ApprovedDormant
BB
69/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
54/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Obesity, Visceral cohort.

Asset / SponsorPhaseRating
Liraglutide
University of Texas Southwestern Medical Center
Phase 4BB
Empagliflozin
University of Texas Southwestern Medical Center
Phase 4BB
Metformin
University of Texas Southwestern Medical Center
Phase 4BB

Same molecule, other indications

GLYCERIN,ANHYDROUS is also rated in:

Low Anterior Resection SyndromeDormant
B
Indicative ·
60 / 100
View asset →
rectal carcinomaDormant
CCC
Indicative ·
54 / 100
View asset →
type 2 diabetes mellitusDormant
CCC
Indicative ·
51 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →